In addition, NEDD4 targets fructose-bisphosphatase 1 (FBP 1) and inhibits FBP1 expression by ubiquitination, i.e., NFATC2 promotes the malignant progression of CCA via the NEDD4/FBP1 axis. Here, NEDD4 is linked to cholangiocarcinoma.